"リゲル" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonRear Admiral Rigel D. Pirrone - navy.mil
Rear Admiral Rigel D. Pirrone navy.mil
Rigel Reports Third Quarter 2025 Financial Results and Provides Business Update - PR Newswire
Rigel Reports Third Quarter 2025 Financial Results and Provides Business Update PR Newswire
Rigel Pharmaceuticals: Continued Financial Performance, Catalysts In 2026 (RIGL) - Seeking Alpha
Rigel Pharmaceuticals: Continued Financial Performance, Catalysts In 2026 (RIGL) Seeking Alpha
Rigel Pharmaceuticals, Inc. (RIGL) Releases Preliminary Results for Q4 2025 - Yahoo Finance
Rigel Pharmaceuticals, Inc. (RIGL) Releases Preliminary Results for Q4 2025 Yahoo Finance
Rigel Provides Business Update and 2026 Outlook - BioSpace
Lilly pulls out of CNS portion of $960M RIPK1 inhibitor collab with Rigel - Fierce Biotech
Lilly pulls out of CNS portion of $960M RIPK1 inhibitor collab with Rigel Fierce Biotech
Rigel enrols first subject in R289 Phase Ib expansion for MDS - Clinical Trials Arena
Rigel enrols first subject in R289 Phase Ib expansion for MDS Clinical Trials Arena
Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lowe...
Is Rigel Pharmaceuticals (RIGL) 2026 Revenue Guidance Reframing Its Commercial-Led Investment Nar...
Is Rigel Pharmaceuticals (RIGL) 2026 Revenue Guidance Reframing Its Commercial-Led Investment Narrative? Yahoo Finance
Rigel Pharmaceuticals: Behind The Huge Rally (NASDAQ:RIGL) - Seeking Alpha
Rigel Pharmaceuticals: Behind The Huge Rally (NASDAQ:RIGL) Seeking Alpha
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - PR...
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) PR Newswire
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Ya...
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) Yahoo Finance
Rigel to Present at the Jefferies Global Healthcare Conference in London - PR Newswire
Rigel to Present at the Jefferies Global Healthcare Conference in London PR Newswire
How Recent Developments Are Rewriting the Story for Rigel Pharmaceuticals - Yahoo Finance
How Recent Developments Are Rewriting the Story for Rigel Pharmaceuticals Yahoo Finance
Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology...
Rigel Pharmaceuticals (RIGL) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
Rigel Pharmaceuticals (RIGL) is a Great Momentum Stock: Should You Buy? Yahoo Finance
Rigel Reports Second Quarter 2025 Financial Results and Provides Business Update - PR Newswire
Rigel Reports Second Quarter 2025 Financial Results and Provides Business Update PR Newswire
Rigel Pharmaceuticals, Inc. (RIGL) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Rigel Pharmaceuticals, Inc. (RIGL) Hit a 52 Week High, Can the Run Continue? Yahoo Finance
Rigel Announces Publication of Final 5-year Data on REZLIDHIA® (olutasidenib) in Patients with R/...
Rigel Pharmaceuticals (RIGL) Tops Q3 Earnings and Revenue Estimates - Yahoo Finance
Rigel Pharmaceuticals (RIGL) Tops Q3 Earnings and Revenue Estimates Yahoo Finance
Rigel Gears Up to Report Q3 Earnings: Here's What to Expect - Yahoo Finance
Rigel Gears Up to Report Q3 Earnings: Here's What to Expect Yahoo Finance
Margie A. (Rigel) Brown - news.thesunontheweb.com
Margie A. (Rigel) Brown news.thesunontheweb.com
Darrell Rigel, MD, MS, on Real-World Advancements in Actinic Keratosis Management - Dermatology T...
Darrell Rigel, MD, MS, on Real-World Advancements in Actinic Keratosis Management Dermatology Times
With EPS Growth And More, Rigel Pharmaceuticals (NASDAQ:RIGL) Makes An Interesting Case - Yahoo F...
With EPS Growth And More, Rigel Pharmaceuticals (NASDAQ:RIGL) Makes An Interesting Case Yahoo Finance
Rigel Pharmaceuticals (RIGL) Profitability Rebound Reinforces Bullish Valuation Narratives - Yaho...
Rigel Pharmaceuticals (RIGL) Profitability Rebound Reinforces Bullish Valuation Narratives Yahoo Finance
Laura R. (Cupp) Rigel Obituary May 5, 2024 - Love-Heitmeyer Funeral Home
Laura R. (Cupp) Rigel Obituary May 5, 2024 Love-Heitmeyer Funeral Home
Rigel Reports First Quarter 2025 Financial Results and Provides Business Update - PR Newswire
Rigel Reports First Quarter 2025 Financial Results and Provides Business Update PR Newswire
What Does Wall Street Think About Rigel Pharmaceuticals (RIGL)? - Yahoo Finance
What Does Wall Street Think About Rigel Pharmaceuticals (RIGL)? Yahoo Finance
A Look At The Intrinsic Value Of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Yahoo Finance
A Look At The Intrinsic Value Of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Yahoo Finance
Rigel Pharmaceuticals (RIGL) Is Up 21.7% After Strong Q3 Results and Raised 2025 Guidance - Yahoo...
Rigel Pharmaceuticals (RIGL) Is Up 21.7% After Strong Q3 Results and Raised 2025 Guidance Yahoo Finance
Douglas Rigel Obituary - Ontario, OH - Dignity Memorial
Douglas Rigel Obituary - Ontario, OH Dignity Memorial
Rigel Pharmaceuticals' (NASDAQ:RIGL) Earnings Are Of Questionable Quality - Yahoo Finance
Rigel Pharmaceuticals' (NASDAQ:RIGL) Earnings Are Of Questionable Quality Yahoo Finance
Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress - PR Ne...
Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress PR Newswire
What Makes Rigel Pharmaceuticals (RIGL) a Strong Momentum Stock: Buy Now? - Yahoo Finance
What Makes Rigel Pharmaceuticals (RIGL) a Strong Momentum Stock: Buy Now? Yahoo Finance
Rigel Pharma: Formulating A Game Plan For 2026 - Seeking Alpha
Rigel Pharma: Formulating A Game Plan For 2026 Seeking Alpha
Dawn Elizabeth Rigel Aston Moore | Obituaries - LancasterOnline
Dawn Elizabeth Rigel Aston Moore | Obituaries LancasterOnline
Rigel Pharma: Q3 Earnings Showcase Robust Growth (NASDAQ:RIGL) - Seeking Alpha
Rigel Pharma: Q3 Earnings Showcase Robust Growth (NASDAQ:RIGL) Seeking Alpha
Rigel Pharmaceuticals, Inc. (RIGL) Soars to 52-Week High, Time to Cash Out? - Yahoo Finance
Rigel Pharmaceuticals, Inc. (RIGL) Soars to 52-Week High, Time to Cash Out? Yahoo Finance
Rigel Pharmaceuticals, Inc. (RIGL) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Rigel Pharmaceuticals, Inc. (RIGL) Hits Fresh High: Is There Still Room to Run? Yahoo Finance
Surging Earnings Estimates Signal Upside for Rigel (RIGL) Stock - Yahoo Finance
Surging Earnings Estimates Signal Upside for Rigel (RIGL) Stock Yahoo Finance
Rigel (RIGL) Loses 27.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo...
Rigel (RIGL) Loses 27.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Yahoo Finance
Rigel Gains 77% in 3 Months: Is This an Indication to Buy the Stock? - Yahoo Finance
Rigel Gains 77% in 3 Months: Is This an Indication to Buy the Stock? Yahoo Finance
Instagrammable eCooler Is Built Like a Tank: TRAVOCA Rigel 25 Dual Zone Review - GearJunkie
Instagrammable eCooler Is Built Like a Tank: TRAVOCA Rigel 25 Dual Zone Review GearJunkie
Results: Rigel Pharmaceuticals, Inc. Exceeded Expectations And The Consensus Has Updated Its Esti...
Results: Rigel Pharmaceuticals, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates Yahoo Finance
Should Value Investors Buy Rigel Pharmaceuticals (RIGL) Stock? - Nasdaq
Should Value Investors Buy Rigel Pharmaceuticals (RIGL) Stock? Nasdaq
Rigel Pharmaceuticals: Strong Growth Trajectory And Commercial Expansion (NASDAQ:RIGL) - Seeking ...
Rigel Pharmaceuticals: Strong Growth Trajectory And Commercial Expansion (NASDAQ:RIGL) Seeking Alpha
Rigel Pharmaceuticals jumps on 2025 revenue guidance boost, Q3 beats - Seeking Alpha
Rigel Pharmaceuticals jumps on 2025 revenue guidance boost, Q3 beats Seeking Alpha
Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Price Is Right But Growth Is Lacking After Shares Roc...
Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Price Is Right But Growth Is Lacking After Shares Rocket 35% simplywall.st
Rigel Pharmaceuticals (RIGL) Price Target Increased by 11.74% to 43.69 - Nasdaq
Rigel Pharmaceuticals (RIGL) Price Target Increased by 11.74% to 43.69 Nasdaq
Insiders Who Sold Rigel Pharmaceuticals Made The Right Call As Market Cap Slides By US$97m - simp...
Insiders Who Sold Rigel Pharmaceuticals Made The Right Call As Market Cap Slides By US$97m simplywall.st
Rigel Pharmaceuticals: Q2 Earnings Fuel A Potential Breakout - Seeking Alpha
Rigel Pharmaceuticals: Q2 Earnings Fuel A Potential Breakout Seeking Alpha
Rigel Pharmaceuticals (RIGL) Turns Profitable, But Guidance for Earnings Decline Challenges Bulli...
Rigel Pharmaceuticals (RIGL) Turns Profitable, But Guidance for Earnings Decline Challenges Bullish Narratives simplywall.st
TRAVOCA Launches Kickstarter for Rigel Dual-Zone eCooler - Outdoor Sportswire
TRAVOCA Launches Kickstarter for Rigel Dual-Zone eCooler Outdoor Sportswire
With 65% institutional ownership, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is a favorite amongst...
With 65% institutional ownership, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is a favorite amongst the big guns Yahoo Finance
H.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL), Sets a $57 PT - Yahoo Fi...
H.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL), Sets a $57 PT Yahoo Finance
Rigel Pharmaceuticals Inc (RIGL) Q2 2025 Earnings Call Highlights: Record Revenue and Raised ... ...
Rigel Pharmaceuticals Inc (RIGL) Q2 2025 Earnings Call Highlights: Record Revenue and Raised ... Yahoo Finance
Can Tavalisse Drive Rigel's Growth Through the Rest of 2025? - Yahoo Finance
Can Tavalisse Drive Rigel's Growth Through the Rest of 2025? Yahoo Finance
Rigel Pharmaceuticals (RIGL) Just Flashed Golden Cross Signal: Do You Buy? - Yahoo Finance
Rigel Pharmaceuticals (RIGL) Just Flashed Golden Cross Signal: Do You Buy? Yahoo Finance
Is Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Trading At A 23% Discount? - simplywall.st
Is Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Trading At A 23% Discount? simplywall.st
Should Value Investors Buy Rigel Pharmaceuticals (RIGL) Stock? - Nasdaq
Should Value Investors Buy Rigel Pharmaceuticals (RIGL) Stock? Nasdaq
Rigel Announces Settlement Agreement Resolving TAVALISSE® (fostamatinib disodium hexahydrate) Pat...
Institutional investors have a lot riding on Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) with 65% o...
Institutional investors have a lot riding on Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) with 65% ownership simplywall.st
Maria Rigel • Director of Thus Spoke the Wind - Cineuropa
Rigel Pharmaceuticals Inc expected to post earnings of 85 cents a share - Earnings Preview - Trad...
Rigel Pharmaceuticals Inc expected to post earnings of 85 cents a share - Earnings Preview TradingView
Alfonzo Rigel Obituary in Durham at American Cremation and Funeral Service - articobits.com
Alfonzo Rigel Obituary in Durham at American Cremation and Funeral Service articobits.com
AllOutdoor Review – Travoca Rigel 45 Dual Zone eCooler - AllOutdoor.com
AllOutdoor Review – Travoca Rigel 45 Dual Zone eCooler AllOutdoor.com
Rigel Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - ...
Rigel Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update PR Newswire
Rigel Gains 77% in 3 Months: Is This an Indication to Buy the Stock? - TradingView
Rigel Gains 77% in 3 Months: Is This an Indication to Buy the Stock? TradingView
Rigel Pharmaceuticals, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Pr...
Rigel Pharmaceuticals, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions simplywall.st
Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) CEO Compensation Looks Acceptable To Us And Here's Wh...
Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) CEO Compensation Looks Acceptable To Us And Here's Why simplywall.st
Rigel Pharmaceuticals (RIGL) Stock Skyrockets on Earnings Beat – Latest Drug Updates & Analyst Ou...
TRAVOCA Debuts the Rigel 60DZ eCooler - stupidDOPE
TRAVOCA Debuts the Rigel 60DZ eCooler stupidDOPE
Wartales: The Curse of Rigel DLC Arrives Next Week - Bleeding Cool News
Wartales: The Curse of Rigel DLC Arrives Next Week Bleeding Cool News
Look for the Witch Head nebula this Halloween night - EarthSky
Look for the Witch Head nebula this Halloween night EarthSky
Rigel Pharmaceuticals: 3-Drug Company Reaches Profitability (RIGL) - Seeking Alpha
Rigel Pharmaceuticals: 3-Drug Company Reaches Profitability (RIGL) Seeking Alpha
Pulp Fiction at Its Pulpiest: Invaders from Rigel by Fletcher Pratt - Reactor
Pulp Fiction at Its Pulpiest: Invaders from Rigel by Fletcher Pratt Reactor
Behind the badge: Artist/Sheriff Danny Rigel - WDAM-TV
Moon Rigel Max - Cycling News | Bike Reviews - Road.cc
Travelmarvel Rigel Ship Review - Cruise Critic
Travelmarvel Rigel Ship Review Cruise Critic
Wartales Expansion: The Curse of Rigel DLC Release Date & Details - Tbreak Media
Wartales Expansion: The Curse of Rigel DLC Release Date & Details Tbreak Media
Rigel's Fostamatinib Being Studied by National Institute of Health in Patients with Sickle Cell D...
Rigel's Fostamatinib Being Studied by National Institute of Health in Patients with Sickle Cell Disease PR Newswire
Rigel Pharmaceuticals Acquires U.S. Rights to GAVRETO® - PR Newswire
Rigel Pharmaceuticals Acquires U.S. Rights to GAVRETO® PR Newswire
Rigel Announces Availability of REZLIDHIA™ (olutasidenib) in the U.S. for the Treatment of Adult ...
Berkeley Councilmember Rigel Robinson to step down, end run for mayor, citing 'harassment, stalki...
Berkeley Councilmember Rigel Robinson to step down, end run for mayor, citing 'harassment, stalking and threats' Berkeleyside
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS - PR Newswire
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS PR Newswire
MD Anderson and Rigel collaborate to advance olutasidenib in AML - MD Anderson Cancer Center
MD Anderson and Rigel collaborate to advance olutasidenib in AML MD Anderson Cancer Center
Rigel Provides Business Update and 2025 Outlook - PR Newswire
Rigel Provides Business Update and 2025 Outlook PR Newswire
Rigel Pharmaceuticals Issues Dear Healthcare Provider Letter for GAVRETO® (pralsetinib) - PR News...
Rigel Pharmaceuticals Issues Dear Healthcare Provider Letter for GAVRETO® (pralsetinib) PR Newswire
Rigel Technology (S) Pte Ltd - MOE
Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th A...
Rigel Announces R289 Granted Orphan Drug Designation by the FDA for MDS - PR Newswire
Rigel Announces R289 Granted Orphan Drug Designation by the FDA for MDS PR Newswire
Rigel Expands Relationship with Kissei to include REZLIDHIA® (olutasidenib) in Japan, the Republi...
Rigel Pharmaceuticals Provides Business Update - PR Newswire
Rigel Pharmaceuticals Provides Business Update PR Newswire
Obituary for Vonda Mae Rigel - shirleyandstout.com
Obituary for Vonda Mae Rigel shirleyandstout.com
Rigel Cabinetry launches digital catalog - LBM Journal
Rigel Cabinetry launches digital catalog LBM Journal
Rigel Pharmaceuticals Completes Transfer of GAVRETO® (pralsetinib) New Drug Application - PR News...
Rigel Pharmaceuticals Completes Transfer of GAVRETO® (pralsetinib) New Drug Application PR Newswire
Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical Officer - PR ...
Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical Officer PR Newswire
2022 January 24 - Rigel and the Witch Head Nebula - NASA (.gov)
2022 January 24 - Rigel and the Witch Head Nebula NASA (.gov)
Obituary for Cynthia S. Rigel - Hanneman Family Funeral Homes & Crematory
Obituary for Cynthia S. Rigel Hanneman Family Funeral Homes & Crematory
Rigel wins US approval of rival drug to Servier leukemia treatment - BioPharma Dive
Rigel wins US approval of rival drug to Servier leukemia treatment BioPharma Dive